# Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)

> **NCT05649865** · — · RECRUITING · sponsor: **Region Skane** · enrollment: 150 (estimated)

## Conditions studied

- Oropharynx Squamous Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample

## Key facts

- **NCT ID:** NCT05649865
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-15
- **Primary completion:** 2027-05
- **Final completion:** 2028-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05649865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05649865, "Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05649865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*